SkinVision Company

SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.

Connections from

Technology: Diagnostics and consultation
Industry: Data processing
Headquarters: Amsterdam, Noord-Holland, The Netherlands
Founded Date: 2012-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 16544305
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-02-10
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership